GO:0044794 host-mediated activation of viral process: Viral Replication Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0044794 (host-mediated activation of viral process) describes how a host organism initiates, promotes, or enhances a viral process during infection.
• Host-mediated post-translational modifications (PTMs) such as phosphorylation, SUMOylation, and ADP-ribosylation are central mechanisms that activate viral replication and pathogenesis.
• The SARS-CoV-2 macrodomain (Mac1) of Nsp3 is a mono-ADP-ribosylhydrolase that reverses host ADP-ribosylation, a key example of host-mediated activation of viral processes.
• Host-mediated phosphorylation of bacterial effector AvrPto by tomato kinases promotes Pseudomonas virulence, illustrating conserved host activation of pathogen processes.
• The SARS-CoV-2 S protein:ACE2 interaction reveals allosteric targets that can be exploited to modulate host-mediated viral activation.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect host genes that activate viral processes.
Description
GO:0044794, host-mediated activation of viral process, is a biological process in which a host organism initiates, promotes, or enhances the normal execution of a biological process mediated by a virus with which it is infected. This term captures the concept that viruses often hijack host cellular machinery and signaling pathways to facilitate their own replication, transcription, translation, and assembly. Understanding this process is critical because it defines the molecular interplay between host and pathogen that determines infection outcomes, tropism, and disease severity. Host-mediated activation of viral process is not limited to animal viruses. In plant-pathogen systems, host-mediated phosphorylation of the type III effector AvrPto by tomato kinases promotes Pseudomonas virulence, demonstrating that host enzymatic activities can directly activate pathogen effector functions. Similarly, in RNA virus pathogenesis, host-mediated post-translational modifications (PTMs) such as phosphorylation, ubiquitination, SUMOylation, and ADP-ribosylation regulate viral protein stability, activity, and interactions with host factors. These modifications can either restrict or enhance viral processes, and viruses have evolved mechanisms to exploit them for their benefit. The SARS-CoV-2 pandemic has highlighted the importance of host-mediated activation of viral process. The conserved macrodomain Mac1 of the viral nonstructural protein 3 (Nsp3) functions as a mono-ADP-ribosylhydrolase that removes ADP-ribose from host proteins, counteracting host antiviral ADP-ribosylation and thereby promoting viral replication. The interaction between the SARS-CoV-2 spike (S) protein and the host receptor ACE2 reveals allosteric sites that can be targeted to interfere with viral entry and activation. These examples underscore that host-mediated activation of viral process is a rich source of therapeutic targets and a key area for CRISPR-based functional genomics.
host-mediated activation of viral process At A Glance
| GO ID | GO:0044794 |
|---|---|
| GO term | host-mediated activation of viral process |
| Ontology | biological_process |
| Synonym | positive regulation by host of viral process |
| Major function | Host-driven initiation, promotion, or enhancement of viral processes during infection |
| Related viral processes | Viral replication, transcription, translation, assembly, and pathogenesis |
| Key host mechanisms | Post-translational modifications (phosphorylation, SUMOylation, ADP-ribosylation), protein-protein interactions, allosteric regulation |
| Example viral proteins | SARS-CoV-2 Nsp3 macrodomain (Mac1), SARS-CoV-2 spike (S) protein |
| Example host proteins | ACE2, tomato kinases, SUMOylation machinery, ADP-ribosyltransferases |
What Is GO:0044794?
According to the Gene Ontology, GO:0044794 (host-mediated activation of viral process) is defined as a process in which a host organism initiates, promotes, or enhances the normal execution of a biological process being mediated by a virus with which it is infected. In other words, it describes any host-driven activity that positively regulates a viral function, such as viral replication, transcription, translation, or assembly. The synonym positive regulation by host of viral process captures this meaning. This term is distinct from host-mediated inhibition of viral process, which would describe host activities that restrict viral processes.
Why Is host-mediated activation of viral process Important in Cell Biology?
Host-mediated activation of viral process is a fundamental concept in infection biology because it explains how viruses co-opt host cellular machinery to complete their life cycle. This process determines viral fitness, host range, and disease severity, and it offers numerous targets for antiviral intervention. For example, the SARS-CoV-2 macrodomain Mac1 hydrolyzes ADP-ribosylated substrates, counteracting host antiviral defenses and promoting viral replication. Host-mediated phosphorylation of the Pseudomonas effector AvrPto by tomato kinases is required for virulence, showing that this concept extends beyond viruses to other pathogens. Understanding these mechanisms is essential for developing host-directed therapies that are less prone to resistance than drugs targeting viral proteins directly.
• Defines how host factors promote viral replication and pathogenesis, a central question in virology.
• Identifies host dependency factors that can be targeted for broad-spectrum antiviral therapy.
• Explains the role of host post-translational modifications in regulating viral protein function.
• Provides a framework for understanding host-pathogen co-evolution and species specificity.
• Highlights the importance of ADP-ribosylation and its reversal by viral macrodomains in coronavirus biology.
• Informs CRISPR-based functional genomics screens to discover host genes that activate viral processes.
• Relevant to emerging viral diseases, including SARS-CoV-2 and other RNA viruses.
• Supports development of host-directed therapeutics that may have reduced resistance potential.
• Connects to cancer biology through shared mechanisms of host-mediated activation of pathogenic processes.
• Enables rational design of live-attenuated vaccines by targeting host-mediated activation mechanisms.
What Happens During host-mediated activation of viral process?
Host-mediated post-translational modifications of viral proteins
In simple terms: The host cell chemically modifies viral proteins to make them work better.
Host cells can attach chemical groups such as phosphate, ubiquitin, SUMO, or ADP-ribose to viral proteins, altering their stability, localization, or activity. These post-translational modifications (PTMs) are a major mechanism of host-mediated activation of viral process. For example, host-mediated phosphorylation of the type III effector AvrPto by tomato kinases promotes Pseudomonas virulence, demonstrating that host enzymatic modification of pathogen proteins can enhance pathogenicity. In RNA virus pathogenesis, host PTMs regulate viral replication complexes and immune evasion. SUMOylation of viral proteins has been proposed to modulate their function and may contribute to pathogenic adaptation.
Host-mediated activation of viral entry and fusion
In simple terms: The host cell helps the virus get inside by providing receptors and activating viral entry proteins.
Viral entry is often dependent on host receptors and proteases that activate viral fusion proteins. The SARS-CoV-2 spike (S) protein interacts with the host receptor ACE2, and this interaction reveals allosteric targets that can modulate viral entry. Host proteases such as TMPRSS2 cleave the spike protein, activating it for membrane fusion. This is a clear example of host-mediated activation of viral process, as the host provides both the receptor and the activating protease.
Host-mediated reversal of antiviral ADP-ribosylation
In simple terms: The host uses ADP-ribose tags to fight viruses, but viruses have enzymes that remove these tags to survive.
Host cells use ADP-ribosylation to modify viral and host proteins as an antiviral defense. In response, many viruses encode macrodomains that reverse this modification. The SARS-CoV-2 conserved macrodomain Mac1 of Nsp3 is a mono-ADP-ribosylhydrolase that removes ADP-ribose from host and viral substrates, thereby counteracting host antiviral ADP-ribosylation and promoting viral replication. This is a prime example of host-mediated activation of viral process, where the host's own ADP-ribosylation machinery is manipulated to benefit the virus.
Host-mediated activation of viral transcription and replication
In simple terms: The host provides the machinery and energy for the virus to copy its genome and make viral RNAs.
Many viruses rely on host transcription factors, RNA polymerases, and nucleotide biosynthesis pathways to replicate their genomes and transcribe viral genes. Host-mediated PTMs can regulate the activity of viral replication proteins. For example, host-mediated phosphorylation of viral proteins can enhance their interaction with host factors required for replication. The SARS-CoV-2 macrodomain Mac1 also plays a role in replication by modulating host immune signaling. These processes are essential for viral amplification and are targets for antiviral intervention.
Host-mediated activation of viral assembly and egress
In simple terms: The host helps the virus package its parts and leave the cell to infect new cells.
Viral assembly and egress often require host membrane trafficking, cytoskeletal, and ESCRT machinery. Host-mediated PTMs of viral structural proteins can regulate their assembly into virions. For example, host-mediated SUMOylation of viral proteins may influence their intracellular trafficking and assembly. The interaction between viral proteins and host factors during assembly is a key step in the viral life cycle and represents a point where host processes activate viral production.
Key Genes Involved in GO:0044794 host-mediated activation of viral process
The following genes and proteins are key players in host-mediated activation of viral process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ACE2 | Host receptor for SARS-CoV-2 spike protein, mediates viral entry | Target for antiviral drugs and CRISPR KO to block viral entry |
| TMPRSS2 | Host protease that cleaves and activates SARS-CoV-2 spike protein | Host-directed antiviral target; KO reduces viral entry |
| Nsp3 (Mac1 domain) | Viral macrodomain with mono-ADP-ribosylhydrolase activity, reverses host ADP-ribosylation | Key viral factor in host-mediated activation; target for antivirals |
| AvrPto | Pseudomonas effector phosphorylated by host kinases to promote virulence | Model for host-mediated activation of pathogen process |
| Pto | Tomato kinase that phosphorylates AvrPto | Host kinase involved in activation of pathogen effector |
| SUMO1/2/3 | Small ubiquitin-like modifiers that conjugate to viral and host proteins | Regulate viral protein function and host-pathogen interactions |
| UBC9 | E2 SUMO-conjugating enzyme | Central to SUMOylation of viral proteins |
| PIAS proteins | E3 SUMO ligases | Modulate SUMOylation of viral proteins |
| PARP enzymes | ADP-ribosyltransferases that modify viral and host proteins | Antiviral defense; counteracted by viral macrodomains |
| STAT1 | Host transcription factor activated by interferon signaling | Regulates antiviral gene expression; can be modulated by viral proteins |
| IRF3 | Host transcription factor involved in interferon response | Target of viral antagonism; host-mediated activation of antiviral genes |
| NF-κB | Host transcription factor regulating immune and inflammatory responses | Modulated by viral proteins to enhance viral replication |
| HSP70 | Host chaperone that assists viral protein folding | Supports viral replication; potential antiviral target |
| eIF4E | Host translation initiation factor | Required for viral mRNA translation; target for antiviral strategies |
| G3BP1 | Host stress granule protein | Interacts with viral proteins; role in viral replication |
| ACE2 (variant) | Host receptor variant with altered affinity for SARS-CoV-2 spike | Allosteric target for modulating viral entry |
How Is host-mediated activation of viral process Regulated?
Host-mediated activation of viral process is regulated at multiple levels. Host post-translational modifications, including phosphorylation, SUMOylation, and ADP-ribosylation, dynamically control the activity of viral and host proteins during infection. For example, the SARS-CoV-2 macrodomain Mac1 hydrolyzes ADP-ribosylated substrates, thereby regulating the balance between host antiviral ADP-ribosylation and viral countermeasures. Host kinase signaling pathways, such as those involving Pto in tomato, can phosphorylate pathogen effectors and regulate virulence. Additionally, the interaction between the SARS-CoV-2 spike protein and ACE2 is subject to allosteric regulation, which can be exploited to modulate viral entry. These regulatory mechanisms are potential targets for therapeutic intervention.
host-mediated activation of viral process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ACE2 | COVID-19 susceptibility and severity | CRISPR KO in human airway organoids or ACE2 knock-in mice |
| TMPRSS2 | COVID-19 viral entry | TMPRSS2 KO cell lines and mouse models |
| Nsp3 (Mac1) | SARS-CoV-2 replication and immune evasion | Point mutations in Mac1 catalytic domain to abolish hydrolase activity |
| AvrPto | Pseudomonas syringae virulence in tomato | Tomato kinase (Pto) knockout and AvrPto phosphorylation mutants |
| SUMOylation machinery | Viral pathogenesis and host immune evasion | SUMO1/2/3 knockout and UBC9 knockdown cell models |
COVID-19 and SARS-CoV-2 pathogenesis
Host-mediated activation of viral process is central to SARS-CoV-2 pathogenesis. The interaction between the viral spike protein and host ACE2, followed by proteolytic activation by TMPRSS2, is a host-mediated activation step essential for viral entry. The viral macrodomain Mac1 reverses host ADP-ribosylation, counteracting antiviral defenses and promoting viral replication. These mechanisms contribute to COVID-19 severity and are targets for antiviral drugs.
Plant bacterial virulence
In plant-pathogen systems, host-mediated phosphorylation of the Pseudomonas effector AvrPto by tomato kinases promotes bacterial virulence, demonstrating that host-mediated activation of pathogen processes is a conserved theme across kingdoms. This mechanism is relevant to crop diseases and agricultural biotechnology.
Cancer and viral oncogenesis
Some viruses exploit host-mediated activation of viral processes to promote oncogenesis. For example, in vitro carcinogenesis studies with cells in early passage have shown that viral infections can cooperate with chemical carcinogens to transform cells. Understanding host-mediated activation of viral processes in oncogenic viruses may reveal targets for cancer prevention and therapy.
From host-mediated activation of viral process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does host gene X activate viral replication? | CRISPR knockout of gene X in permissive cells followed by viral infection |
| Does a specific phosphorylation site on a viral protein mediate host activation? | Point mutation of the phosphorylation site in the viral genome using CRISPR |
| Can a host factor be tagged to track its interaction with viral proteins? | Knock-in of a fluorescent or epitope tag at the endogenous locus |
| Does overexpression of a host factor enhance viral replication? | Overexpression of the host gene using lentiviral or CRISPR activation |
| Which host genes are essential for viral entry? | Genome-wide CRISPR knockout library screening |
| Does a host kinase inhibitor block viral activation? | Pharmacological inhibition in wild-type and kinase-knockout cells |
How to Study the host-mediated activation of viral process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Host genes required for viral replication | Identify host dependency factors for SARS-CoV-2 |
| Phosphoproteomics | Host-mediated phosphorylation of viral and host proteins | Map signaling changes during infection |
| ADP-ribosylation assay | ADP-ribose modification of proteins | Measure macrodomain hydrolase activity |
| Co-immunoprecipitation | Protein-protein interactions | Detect viral-host protein complexes |
| Cryo-EM | High-resolution structures of protein complexes | Visualize spike:ACE2 interaction |
| RNA-seq | Transcriptional changes in host and virus | Measure viral gene expression and host response |
| Western blot | Protein expression and modification levels | Validate knockout or overexpression |
| Luciferase reporter assay | Viral or host promoter activity | Measure viral transcription activation |
CRISPR knockout screening
Genome-wide CRISPR knockout screens are powerful for identifying host genes that are required for viral replication or pathogenesis. Cells are transduced with a lentiviral sgRNA library, selected, and infected with the virus of interest. sgRNAs that are depleted or enriched after infection reveal host dependency factors or restriction factors. This approach has been used to identify host factors for SARS-CoV-2 and other viruses.
Phosphoproteomics and PTM analysis
Mass spectrometry-based phosphoproteomics and other PTM analyses can identify host-mediated modifications on viral and host proteins during infection. For example, phosphorylation of the Pseudomonas effector AvrPto by tomato kinases was discovered using such approaches. These methods are essential for mapping the landscape of host-mediated activation of viral process.
ADP-ribosylation assays
ADP-ribosylation of viral and host proteins can be measured using radiolabeled NAD+ or specific antibodies. The SARS-CoV-2 macrodomain Mac1 hydrolyzes ADP-ribosylated substrates, and its activity can be assayed in vitro and in cells. These assays are critical for understanding how viruses counteract host ADP-ribosylation.
Structural biology and allostery
Structural studies of viral protein-host protein complexes, such as the SARS-CoV-2 spike:ACE2 interaction, reveal allosteric sites that can be targeted to modulate host-mediated activation of viral process. Cryo-EM and X-ray crystallography are commonly used.
How CRISPR Can Be Used to Study GO:0044794 host-mediated activation of viral process
Knockout
CRISPR knockout of host genes is used to determine whether a candidate host factor is required for host-mediated activation of viral process. For example, knockout of ACE2 or TMPRSS2 blocks SARS-CoV-2 entry, confirming their essential roles. Genome-wide knockout screens have identified numerous host dependency factors for viral replication.
Point Mutation
Point mutations can be introduced into viral or host genes to dissect specific residues involved in host-mediated activation. For example, mutation of the catalytic residue in the SARS-CoV-2 macrodomain Mac1 abolishes its ADP-ribosylhydrolase activity, revealing its role in counteracting host antiviral defenses. Similarly, mutation of phosphorylation sites in the Pseudomonas effector AvrPto can prevent host-mediated activation.
Knock-in
Knock-in of tags or reporter genes at endogenous loci allows tracking of host or viral proteins during infection. For example, knock-in of a fluorescent tag on a host factor can reveal its localization and interaction with viral proteins. Knock-in of viral genes with epitope tags facilitates purification and functional studies.
Overexpression
Overexpression of host genes can test whether a factor is sufficient to enhance viral replication or activation. For example, overexpression of ACE2 in non-permissive cells can confer susceptibility to SARS-CoV-2. Overexpression of host kinases can increase phosphorylation of viral effectors and promote virulence.
How EDITGENE Supports host-mediated activation of viral process Research
Researchers studying host-mediated activation of viral process-related genes often need to determine whether a candidate gene is causally involved in viral replication, pathogenesis, or immune evasion. This requires precise genetic manipulation, including knockout, point mutation, knock-in, and overexpression, followed by functional assays. EDITGENE provides comprehensive CRISPR-based services to accelerate these studies.
Contact EDITGENE today to design your custom CRISPR model for host-mediated activation of viral process research.
Frequently Asked Questions About host-mediated activation of viral process
What is GO:0044794 host-mediated activation of viral process?
GO:0044794 is a Gene Ontology biological process term defined as a process in which a host organism initiates, promotes, or enhances the normal execution of a biological process being mediated by a virus with which it is infected.
What genes are involved in host-mediated activation of viral process?
Key genes include ACE2 and TMPRSS2 for SARS-CoV-2 entry, the viral Nsp3 macrodomain Mac1 for counteracting host ADP-ribosylation, and host SUMOylation machinery components such as UBC9 and PIAS proteins.
How does host-mediated activation of viral process work?
The host provides receptors, proteases, and post-translational modification machinery that modify viral proteins or host factors to enhance viral replication, transcription, assembly, and egress.
Why is host-mediated activation of viral process important for COVID-19?
SARS-CoV-2 exploits host ACE2 for entry and the viral macrodomain Mac1 to reverse host antiviral ADP-ribosylation, both of which are examples of host-mediated activation of viral process and contribute to viral pathogenesis.
What are examples of host-mediated activation of viral process?
Examples include host-mediated phosphorylation of the Pseudomonas effector AvrPto by tomato kinases, ACE2-mediated SARS-CoV-2 entry, and macrodomain-mediated reversal of ADP-ribosylation.
How can CRISPR be used to study host-mediated activation of viral process?
CRISPR knockout, point mutation, knock-in, and overexpression can be used to test the role of specific host or viral genes in activating viral processes. Genome-wide CRISPR screens can identify novel host dependency factors.
What is the role of post-translational modifications in host-mediated activation of viral process?
Host-mediated PTMs such as phosphorylation, SUMOylation, and ADP-ribosylation regulate viral protein stability, activity, and interactions, thereby modulating viral replication and pathogenesis.
Which viruses are known to exploit host-mediated activation?
Many viruses, including SARS-CoV-2, other RNA viruses, and plant pathogens such as Pseudomonas syringae, exploit host-mediated activation mechanisms.
What model systems are used to study host-mediated activation of viral process?
Common models include human cell lines, organoids, mouse models, and plant models such as tomato for studying effector phosphorylation.
How does the SARS-CoV-2 macrodomain Mac1 contribute to host-mediated activation of viral process?
Mac1 is a mono-ADP-ribosylhydrolase that removes ADP-ribose from host proteins, counteracting antiviral ADP-ribosylation and promoting viral replication, thus representing a viral mechanism that exploits host processes.
Conclusion
GO:0044794 host-mediated activation of viral process is a critical biological process that describes how hosts promote viral replication and pathogenesis. From host-mediated phosphorylation of pathogen effectors to the reversal of antiviral ADP-ribosylation by viral macrodomains, these mechanisms are central to infection biology and offer numerous targets for therapeutic intervention. Understanding these processes requires precise genetic tools, and CRISPR-based knockout, point mutation, knock-in, and overexpression models are indispensable for dissecting the underlying molecular mechanisms. As new viruses emerge, research into host-mediated activation of viral process will continue to inform the development of host-directed antivirals and vaccines.
References
- 1. Kumar R et al.. 2020. Role of Host-Mediated Post-Translational Modifications (PTMs) in RNA Virus Pathogenesis.. Int J Mol Sci 22(1) PMID: 33396899
- 2. Raghuvamsi PV et al.. 2021. SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets.. Elife 10 PMID: 33554856
- 3. Anderson JC et al.. 2006. Host-mediated phosphorylation of type III effector AvrPto promotes Pseudomonas virulence and avirulence in tomato.. Plant Cell 18(2):502-14 PMID: 16399801
- 4. Alhammad YMO et al.. 2021. The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase.. J Virol 95(3) PMID: 33158944
- 5. Chea C et al.. 2023. Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates.. bioRxiv PMID: 36945431
- 6. Alhammad YMO et al.. 2020. The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.. bioRxiv PMID: 32511412
- 7. Sahin U. 2026. Cas9 beyond CRISPR - SUMOylation, effector-like potential and pathogenic adaptation.. FEBS J 293(5):1285-1296 PMID: 40898426
- 8. DiPaolo JA et al.. 1978. In vitro carcinogenesis with cells in early passage.. Natl Cancer Inst Monogr PMID: 372816
